The a-subunit of the heterotrimeric G protein G13 regulate cell growth, dierentiation and apoptosis in dierent cell types. Expression of the constitutively activated mutant of Ga 13 (Ga 13 QL) increases the expression of Egr-1, an immediate-early response gene that is identi®ed to be involved in cell growth, dierentiation, and apoptosis. Here we report that Ga 13 QL activates the promoter of Egr-1 through speci®c sequence which includes the characteristic CArG boxes. We also demonstrate that the Ga 13 QL activation of Egr-1 promoter is mediated by the Ras-like small GTPase Rho.
G 13 belongs to the G12 class of heterotrimeric G proteins (Dhanasekaran and Dermott, 1996) . The asubunit of G 13 regulates the critical responses involved in cell growth, dierentiation, and apoptosis (Jiang et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994; Xu et al., 1994; Althoefer et al., 1997; Jho and Malbon, 1997; Dhanasekaran and Dermott, 1996) . While the expression of the activated mutant of Ga 13 induces the oncogenic transformation of NIH3T3 and Rat1 cells (Jiang et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994; Xu et al., 1994) , it induces apoptosis in COS and CHO cells (Althoefer et al., 1997) . In addition, Ga 13 appears to mediate the retinoic acid-induced dierentiation of P19 embryonic carcinoma cells (Jho and Malbon, 1997) . These ®ndings, along with the observation that Ga 13 is involved in the regulation of embryonic angiogenesis (Oermanns et al., 1997) , suggest that Ga 13 is involved in the regulation of several dierent, some times opposing, critical responses in a cell type-speci®c manner. However, the Ga 13 -regulated cell type-speci®c signaling mechanism that activates these multiple pathways, has not been identi®ed. In this context, the ability of Ga 13 to activate the expression of early growth response factor-1 or Egr-1 (Vara Prasad et al., 1994) and the ability of Egr-1 to regulate cell proliferation, dierentiation and apoptosis in a cell-type speci®c manner are worth noting (Milbrant, 1987; Sukhatame et al., 1988; Cao et al., 1990; Nguyen et al., 1993; Nair et al., 1997) . This interesting correlation suggests the possibility that the dierential eects of Ga 13 on cell proliferation, dierentiation and apoptosis are functions of Egr-1 and/or the genes regulated by Egr-1. Therefore, we sought to investigate the signaling mechanism by which Ga 13 regulates the expression of Egr-1. The results we have presented here indicate that the GTPase de®cient, oncogenic mutant of Ga 13 (Ga 13 QL) stimulates the expression of Egr-1 through the transactivation of speci®c cis-elements contained within 7550 to 750 sequence of Egr-1 promoter and the activation is strongly mediated by the small GTPase Rho.
In a previous study, we have shown that the expression of GTPase-de®cient, activated mutants of Ga 12 (Ga 12 QL) and Ga 13 (Ga 13 QL) lead to the oncogenic transformation of NIH3T3 cells along with the constitutive expression of the primary response genes c-fos, c-jun and Egr-1. Of these transcription factors, Egr-1 appears to be preferentially regulated by Ga 13 . To investigate whether the stimulation of Egr-1 expression involves the transactivation of its promoter by Ga 13 , we tested the ability of Ga 13 QL to transactivate the promoter of Egr-1. NIH3T3 cells were cotransfected with the vector containing Ga 13 QL insert along with a vector construct containing the full length promoter of Egr-1 that had already been fused to a reporter cDNA encoding chloramphenicol acetyl transferase (CAT) reporter gene (Gius et al., 1990) . When the transfectants were analysed for the CAT activity at 48 h after transfection, the results clearly indicated that the coexpression of Ga 13 QL potently activated the expression of the CAT reporter gene (Figure 1) .
To identify the Ga 13 -responsive region in the promoter sequence of Egr-1, we utilized the dierent Egr-1 promoter-CAT fusion constructs in which the speci®c regions of the Egr-1 promoter had been deleted . It has been shown that the promoter of Egr-1 contains distinct response elements such as AP1 and SREs containing CArG boxes ( Figure 2a ). The Egr-1 promoter construct pEgr-1 p1.2 contains the complete promoter sequence. The construct pD7550/ 750 contains an internal deletion that removes all six CArG boxes, leaving the other cis-elements intact whereas the construct pE425 contains the sequence that includes the six cArG boxes. The construct pE50poly contains the minimal Egr-1 promoter containing a TATA box fused to the CAT gene. NIH3T3 cells were cotransfected with Ga 13 QL plus each of these constructs and the CAT activity was determined at 48 h following transfection. When Ga 13 QL was coexpressed along with Egr-1p1.2, the reporter CAT-activity was stimulated. However, Ga 13 QL failed to activate the Egr-1 minimal promoter construct. The inability of Ga 13 QL-signaling pathway to transactivate the minimal promoter contained within pE50poly suggests that speci®c cis-elements are required for the activation of Egr-1 promoter. Interestingly, when Ga 13 Ql was cotransfected with pE425 that contains the promoter sequence from 7425, a potent activation of the CAT reporter enzyme was observed. In contrast, when Ga 13 QL was cotransfected with pD7550/750, which lacks the sequence 7550 to 50, the CAT-activity was not stimulated. Taken together, these results clearly suggest that the signaling pathway leading from Ga 13 QL transactivates the Egr-1 promoter through the cis-elements present in the Egr-1 promoter and it does not involve the AP1 sites. More signi®cantly, these results point out that the cis-elements contained within the 7425 to 750 sequence confer Ga 13 -responsiveness to the Egr-1 promoter (Figure 2b) .
It has been known that Ras and Raf induce the expression of Egr-1 through the transactivation of Egr-1 promoter (Rim et al., 1992; Watanabe et al., 1997) .
Figure 1 Ga 13 QL activates Egr-1 promoter. NIH3T3 cells were transfected with an expression vector encoding the full-length promoter of Egr-1 (7935 to +265 of EGR-1 sequence) fused to the chloramphenicol acetyltransferase reporter (pEgr-1p1.2) in the presence or absence of Ga 13 QL-expression vector. Forty-eight hours later, the cells were lysed and the CAT assays were carried out as described (Gashler et al., 1993) . NIH3T3 cells were plated at 5610 5 per 100 mm dish. After 18 h, the cells were transfected with calcium phosphate-mediated co-precipitation method. Each precipitate contained 20 ug of DNA (2 ug of the respective Egr-1 promoter-CAT construct, 4 ug of Ga 13 QLpcDNA3 or pcDNA3, 4 ug of the respective dominant negative mutant constructs, and 1 ug of pSV-bGal reporter construct and carrier DNA. Fortyeight hours after transfection, the cell lysates were prepared and the CAT assays were carried out according to the methods of Gorman et al. (1982) . The acetylated [
14 C]-chloramphenol was quanti®ed by the phosphorimage analysis of the acetylated spots using a Fuji Phosphorimager. Variations in the transfection eciency were normalized using the b-galactosidase assay (Rosenthal, 1987) . The experiment was repeated six times with similar results. The relative CAT activity was calculated from the activity of the control group that was considered as one. The results (mean+s.e.) represent the relative CAT activity compared to those of the control group from six independent experiments (upper panel). The results presented as the autoradiogram is from a typical experiment (lower panel) Figure 2 Ga 13 QL activates Egr-1 promoter through a speci®c region. NIH3T3 cells were transfected with expression vectors containing Egr-1 full-length promoter (pEgr-1p1.2) or Egr-1 promoter containing various deletions (pED7550/750, pE425 or pE50poly) in the presence or absence of Ga 13 QL-expression vector. Forty-eight hours later, the CAT activities of the transfectants were analysed. The relative CAT activity was calculated from the activity of the control group which was considered as one. Results presented as bar diagram are derived from a set of three independent experiments (mean+s.e.) whereas results presented as the autoradiogram is from a typical experiment Our previous studies have indicated that Ga 13 stimulates diverse cellular responses through the small GTPases belonging to both the Ras and Rho family of GTPases (Vara Prasad et al., 1995; Dhansekaran and Dermott, 1996; Wadsworth et al., 1997; Buhl et al., 1995) . Since Ras-as well as Rho-dependent pathways have been known to activate SREs of many dierent genes and Rho is involved in the activation of SREs by Ga 12 (Fromm et al., 1997) , we investigated whether the activation of Egr-1 promoter by Ga 13 involves either of the GTPases. The Egr-1-CAT promoter construct, pE425 containing Ga 13 -responsive SREs was coexpressed along with Ga 13 QL and the dominant negative, competitively inhibitory mutants of Ras (N17Ras), Rac (N17Rac) or Rho (N19Rho). The CAT assays were performed at 48 h post transfection. As shown in Figure 3 , the expression of dominant negative Rho strongly inhibited the Ga 13 -mediated activation of Egr-1. The dominant negative Ras also inhibited the promoter activation by Ga 13 , albeit weekly. However, the co-expression of dominant negative Rac failed to inhibit the Ga 13 QL mediated promoter-activation. Similarly the co-expression of dominant negative CDC42 also failed to inhibit the Ga 13 QL mediated promoter-activation (data not shown). These results suggest that Ga 13 activation of EGR-1 involves a predominantly Rho-dependent signaling pathway along with a less dominant Rasdependent pathway.
Since the expression of Egr-1 has been associated with cell proliferation, dierentiation, and apoptosis, it is likely that Ga 13 -activation of Egr-1 plays a major role in the proliferative, dierentiative, and apoptotic pathways regulated by Ga 13 . It has been observed that several growth stimulatory pathways activate Egr-1 through Ras ± Raf pathway. Our observation that Ga 13 QL activation of EGR-1 promoter activation is weakly dependent on functional Ras may be consistent with these observations. However, our ®nding that Egr-1 expression is dependent on the small GTPase Rho, is a novel one. It is more signi®cant in the light of the recent ®ndings that Ga 13 signaling pathway predominantly involves Rho-family of GTPases rather than Ras (Althoefer et al., 1997) . The observations that Rac is not involved in the stimulation of Egr-1 and Ga 13 -activation of Egr-1 expression does not involve AP-1 sites are rather surprising since Ga 13 activates the JNKmodule and subsequent phosphorylation of Jun through Rac. Thus, it appears that while Ga 13 activates JNKsignaling module through Rac, its activation of Egr-1 expression involves Rho. Such multiple signaling inputs from Ga 13 may be required for the varied and complex signaling pathways such as cell shape changes, chemokinesis and cell dierentiation in which Ga 13 plays a critical role.
Although the ability of Ga 13 to activate Rho dependent signaling pathways have been previously shown (Buhl et al., 1995; Hooley et al., 1996) the mechanism by which Ga 13 regulate multiple signaling pathways through Rho remained unclear. Our observation that Ga 13 -activates the pleuripotent transcription factor Egr-1 through Rho suggests that this could be an underlying mechanism through which Ga 13 exerts pleotropic eects in dierent cell-types or during dierent physiological contexts within the same cell type. In this context, it is worth noting that Oermanns et al. (1997) indicated that Ga 13 may be involved in the angiogenic process such as sprouting, migration and remodeling of endothelial cells. Signi®cantly, Egr-1 expression is often associated with sprouting, remodeling and migration of diverse cell types including endothelial cells (Wolf et al., 1996; Micel et al., 1994) . Taken together, these observations suggest the possibility that the regulation of angiogenesis by Ga 13 may involve Egr-1. Similarly, it is possible that the Rhodependent Egr-1 expression activated by Ga 13 plays a crucial role in the Rho-dependent apoptotic pathway activated by Ga 13 in CHO and COS cells (Althoefer et al., 1997) . It is signi®cant to note that the recent observations that Ga 13 physically interacts with p115 Rho-GEF and activates the guanine nucleotide exchange activity of Rho provide a molecular mechanism through which Rho can be activated by Ga 13 Hart et al., 1998) . Therefore Ga 13 mediated activation of Rho as well as Rho activation of Egr-1 is likely to be involved in regulating many other signaling responses yet to be identi®ed. Further analysis of the signal coupling mechanism between Ga 13 -Rho and Egr-1 should ®nally de®ne the mechanism by which Ga 13 regulates the diverse, seemingly opposing, responses in dierent cell types. Figure 3 Rho-dependent Activation of Egr-1 promoter by Ga 13 QL. NIH3T3 cells were transfected with the Ga 13 -responsive Egr-1 promoter construct pE425, along with the dominant negative, competitively inhibitory mutants of Ras (N17Ras), Rac (N17Rac) or Rho (N19Rho) in the presence or absence of Ga 13 QL-expression vector. The expression vectors pcDNA3-Ga 13 Q229L, pCMV5-RasN17, pCMV5-RhoN19, pCEV-RacN17 and their equal levels of expressions in the transient transfection procedure used here, have been previously described (Wadsworth et al., 1997) . The relative CAT activities of the transfectants were determined from the values of the control groups (pE425-transfectants) that were considered as one. Mean+s.e. values were determined from three independent experiments
